What is NovoCure's operating lease liabilities?

NovoCure (NVCR) reported operating lease liabilities of $39.48M in Q1 2026.

How has NovoCure's operating lease liabilities changed year-over-year?

NovoCure's operating lease liabilities decreased by 2.1% year-over-year, from $40.31M to $39.48M.

What is the long-term trend for NovoCure's operating lease liabilities?

Over 5 years (2020 to 2025), NovoCure's operating lease liabilities has grown at a 23.8% compound annual growth rate (CAGR), from $14.29M to $41.65M.

What does operating lease liabilities mean?

Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.

NovoCure NVCR Operating Lease Liabilities

Operating Lease Liabilities at other companies

Iovance Biotherapeutics, Inc.IOVA

$43.88M-0.8%

Nuvation BioNUVB

$2.2M-42.7%

ArriVent BioPharma, Inc.AVBP

$320K—

Ethos Technologies, Inc. LIFE

$10.06M-8.1%

Tango TherapeuticsTNGX

$29.96M-12.2%

BridgeBio PharmaBBIO

$14.22M+189%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's operating lease liabilities?: NovoCure (NVCR) reported operating lease liabilities of $39.48M in Q1 2026.
How has NovoCure's operating lease liabilities changed year-over-year?: NovoCure's operating lease liabilities decreased by 2.1% year-over-year, from $40.31M to $39.48M.
What is the long-term trend for NovoCure's operating lease liabilities?: Over 5 years (2020 to 2025), NovoCure's operating lease liabilities has grown at a 23.8% compound annual growth rate (CAGR), from $14.29M to $41.65M.
What does operating lease liabilities mean?: Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.